@InRite @noraizko Aún conociendo los efectos secundarios de este grupo farmacológico, su beneficio en el ámbito cardiovascular y en diabetes es tan alto, que merece la pena mantenerlo. https://t.co/PgnA63EKwQ
4,848 followers
4,905 followers
RT @FrontCVMedicine: New Research: Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary: A new therapeutic…
2,794 followers
New Research: Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary: A new therapeutic class of oral agents firstly used for the treatment of type 2 diabetes mellitus is represented by gliflozines or… https://t.co/YF8G7N4Tyj